Second Department of Cardiology, University of Athens, Greece
CardioThoracic and Vascular Department, University Hospital-Pisa, Italy.
Europace. 2015 Oct;17(10):1596-600. doi: 10.1093/europace/euv323.
The aim of this survey was to provide insight into current practice regarding ablation of persistent atrial fibrillation (AF) among members of the European Heart Rhythm Association electrophysiology research network. Thirty centres responded to the survey. The main ablation technique for first-time ablation was stand-alone pulmonary vein isolation (PVI): in 67% of the centres for persistent but not long-standing AF and in 37% of the centres for long-standing persistent AF as well. Other applied techniques were ablation of fractionated electrograms, placement of linear lesions, stepwise approach until AF termination, and substrate mapping and isolation of low-voltage areas. However, the percentage of centres applying these techniques during first ablation did not exceed 25% for any technique. When stand-alone PVI was performed in patients with persistent but not long-standing AF, the majority (80%) of the centres used an irrigated radiofrequency ablation catheter whereas 20% of the respondents used the cryoballoon. Similar results were reported for ablation of long-standing persistent AF (radiofrequency 90%, cryoballoon 10%). Neither rotor mapping nor one-shot ablation tools were used as the main first-time ablation methods. Systematic search for non-pulmonary vein triggers was performed only in 10% of the centres. Most common 1-year success rate off antiarrhythmic drugs was 50-60%. Only 27% of the centres knew their 5-year results. In conclusion, patients with persistent AF represent a significant proportion of AF patients undergoing ablation. There is a shift towards stand-alone PVI being the primary choice in many centres for first-time ablation in these patients. The wide variation in the use of additional techniques and in the choice of endpoints reflects the uncertainties and lack of guidance regarding the most optimal approach. Procedural success rates are modest and long-term outcomes are unknown in most centres.
本调查旨在深入了解欧洲心脏病学会心律协会电生理研究网络成员在持续性心房颤动(AF)消融方面的当前实践情况。30 个中心对该调查做出了回应。首次消融的主要消融技术是独立的肺静脉隔离(PVI):在持续性而非长期持续性 AF 的 67%的中心和长期持续性 AF 的 37%的中心中均如此。其他应用的技术包括碎裂电图消融、线性消融、逐步消融直至 AF 终止,以及基质标测和低电压区域隔离。然而,在任何技术中,应用这些技术的中心百分比均不超过 25%。在持续性而非长期持续性 AF 患者中进行独立 PVI 时,大多数(80%)中心使用灌流射频消融导管,而 20%的受访者使用冷冻球囊。对于长程持续性 AF 的消融,也报告了类似的结果(射频 90%,冷冻球囊 10%)。旋转子标测或一次性消融工具均未用作主要的首次消融方法。只有 10%的中心进行系统性搜索非肺静脉触发。最常见的 1 年抗心律失常药物成功率为 50-60%。只有 27%的中心了解其 5 年结果。结论:持续性 AF 患者在接受消融治疗的 AF 患者中占很大比例。在许多中心,对于这些患者的首次消融,独立 PVI 逐渐成为主要选择。在附加技术的应用和终点选择方面存在广泛的差异,反映了对于最优化方法的不确定性和缺乏指导。手术成功率适中,大多数中心均不知道长期结局。